Your Risk For
Preterm Birth
About FDA–Approved
Makena
Makena
Care Connection
Useful Information En Español
  • Your Risk Factors
  • |
  • Reducing Your Risk
  • What Is Makena?
  • |
  • How Makena Can Help
  • |
  • How Safe Is Makena?
  • |
  • Using Makena
  • |
  • Benefits Of FDA Approval
  • Makena Access
  • Educational Materials
  • |
  • Tell A Friend
  • Acceso a Makena
  • |
  • Materiales educativos
  • |
  • Cuénteselo a una amiga

Looking for more information about pregnancy or preterm birth?


Share information about how Makena® (hydroxyprogesterone caproate injection) may help moms stay pregnant longer


The number of preterm babies born each year is greater than it has ever been in the US—and it continues to grow.1,2 Chances are you have family or friends who have experienced a preterm birth. Share with them how Makena can help reduce the risk for another preterm birth.


Just follow the simple instructions to send an e-postcard.


Step 1

Choose an e-postcard banner.




Step 2

Enter the sender's and recipient's information.


Sender's name:*
 
Sender's e-mail:*
 
Recipient's name:*
 
Recipient's e-mail:*
 
Your message (optional):
 

Step 3

Review your message using the Preview button.


     

The e-mail address you submit will only be used to send a single message to
your friend to let her know about this site.

Ther-Rx Corporation, Inc., does not otherwise store, sell, trade, or release the
e-mail addresses or names of friends or family that you have shared with us,
except as required by law.

Review our Terms of Use of Site statement for more information.





Makena® is a prescription hormone medicine (progestin) used to lower the risk of preterm birth in women who are pregnant with one baby and who have delivered one baby too early (preterm) in the past. Makena was shown to work based on a lower number of women who delivered babies at less than 37 weeks of pregnancy. There are no studies showing Makena reduces the number of babies who have serious problems shortly after birth or who die. It is not known whether Makena is safe and effective in women who have other risk factors for preterm birth.

Important safety information for Makena (hydroxyprogesterone caproate injection)

Makena should not be used in women with any of the following conditions: blood clots or other blood clotting problems, breast cancer or other hormone-sensitive cancers, or history of these conditions; unusual vaginal bleeding not related to your current pregnancy, yellowing of the skin due to liver problems during pregnancy, liver problems, including liver tumors, or uncontrolled high blood pressure.

Before you receive Makena, tell your healthcare provider if you have an allergy to hydroxyprogesterone caproate, castor oil, or any of the other ingredients in Makena; diabetes or prediabetes, epilepsy, migraine headaches, asthma, heart problems, kidney problems, depression, or high blood pressure.

In a clinical study, certain complications or events associated with pregnancy occurred more often in women who received Makena. These included miscarriage (pregnancy loss before 20 weeks of pregnancy), stillbirth (fetal death occurring during or after the 20th week of pregnancy), hospital admission for preterm labor, preeclampsia (high blood pressure and too much protein in your urine), gestational hypertension (high blood pressure caused by pregnancy), gestational diabetes, and oligohydramnios (low amniotic fluid levels).

Makena may cause serious side effects including blood clots, allergic reactions, depression, and yellowing of your skin and the whites of your eyes. Call your healthcare provider right away if you think you have symptoms of a blood clot (leg swelling, redness in your leg, a spot on your leg that is warm to touch, or leg pain that worsens when you bend your foot) or symptoms of an allergic reaction (hives, itching, or swelling of the face). The most common side effects of Makena include injection site reactions (pain, swelling, itching, bruising, or a hard bump), hives, itching, nausea, and diarrhea.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see full prescribing information for Makena.


References: 1. March of Dimes Foundation. March of Dimes®. Available at: www.marchofdimes.com. Accessed October 20, 2009. 2. Martin JA, Hamilton BE, Sutton PD, et al, for the Division of Vital Statistics. Births: final data for 2006. Natl Vital Stat Rep. 2009;57:1-104.




  • Home
  • |
  • Contact Us
  • |
  • Site Directory
  • |
  • Safety Information
  • |
  • Prescribing Information
  • |
  • About Ther-Rx

Ther-Rx
©2012 Ther-Rx Corporation Terms of Use of Site